Ramesh Elango

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Prognostic Factors

Top Venues

Cell death discovery

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Ramesh Elango, Vishnubalaji Radhakrishnan, Sameera Rashid, Reem Al-Sarraf, Mohammed Akhtar, Khalid Ouararhni, Nehad M Alajez
Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression. Cell death discovery 10 (1) (2024)
Ramesh Elango, Vishnubalaji Radhakrishnan, Sameera Rashid, Reem Al-Sarraf, Mohammed Akhtar, Khalid Ouararhni, Nehad M Alajez
Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression. Cell death discovery 10 (1) (2024)
Ramesh Elango, Vishnubalaji Radhakrishnan, Sameera Rashid, Reem Al-Sarraf, Mohammed Akhtar, Khalid Ouararhni, Nehad M Alajez
Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression. Cell death discovery 10 (1) (2024)
Ramesh Elango, Sameera Rashid, Radhakrishnan Vishnubalaji, Reem Al-Sarraf, Mohammed Akhtar, Khalid Ouararhni, Julie V Decock, Omar M E Albagha, Nehad M Alajez
Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. Cell death & disease 14 (7) (2023)
Radhakrishnan Vishnubalaji, Ramesh Elango, Nehad M Alajez
LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities. Non-coding RNA 8 (4) (2022)